Yu‐Pei Chen

11.4k total citations · 2 hit papers
135 papers, 5.5k citations indexed

About

Yu‐Pei Chen is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Yu‐Pei Chen has authored 135 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Otorhinolaryngology, 44 papers in Oncology and 33 papers in Surgery. Recurrent topics in Yu‐Pei Chen's work include Head and Neck Cancer Studies (50 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Yu‐Pei Chen is often cited by papers focused on Head and Neck Cancer Studies (50 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Yu‐Pei Chen collaborates with scholars based in China, Taiwan and United States. Yu‐Pei Chen's co-authors include Jun Ma, Ying Sun, Quynh‐Thu Le, Anthony T.�C. Chan, Pierre Blanchard, Ling‐Long Tang, Yan‐Ping Mao, Guan‐Qun Zhou, Lei Chen and Ai-Hua Lin and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yu‐Pei Chen

127 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nasopharyngeal carcinoma

2019 2.0k citations Yu‐Pei Chen, Anthony T.�C. Chan et al. profile →
Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis

2018 416 citations Cheng Xu, Yu‐Pei Chen et al. profile →

Peers

Countries citing papers authored by Yu‐Pei Chen

Since Specialization

Citations

This map shows the geographic impact of Yu‐Pei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Pei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Pei Chen more than expected).

Fields of papers citing papers by Yu‐Pei Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Pei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Pei Chen. The network helps show where Yu‐Pei Chen may publish in the future.

Co-authorship network of co-authors of Yu‐Pei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Pei Chen. A scholar is included among the top collaborators of Yu‐Pei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Pei Chen. Yu‐Pei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Segmentation and multiparametric evaluation of corneal whorl-like nerves for in vivo confocal microscopy images in dry eye disease 2024 ·BMJ Open Ophthalmology ·Yu Kang, Yu‐Pei Chen, (unknown), (unknown), Yuqing Deng, (unknown), (unknown), (unknown), Peng Xiao, Jin Yuan	1
2	Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study 2022 ·Radiation Oncology ·(unknown), Kai‐Bin Yang, Ying Huang, (unknown), (unknown), Lei Chen, Wen‐Fei Li, Xiaodan Huang, Li Lin, Yu‐Pei Chen, Yan‐Ping Mao, Ling‐Long Tang, Jun Ma	5
3	Long-Term Evaluation and Normal Tissue Complication Probability (NTCP) Models for Predicting Radiation-Induced Optic Neuropathy after Intensity-Modulated Radiation Therapy (IMRT) for Nasopharyngeal Carcinoma: A Large Retrospective Study in China 2022 ·Journal of Oncology ·(unknown), Wen‐Fei Li, Kai‐Bin Yang, Lei Chen, (unknown), Fo‐Ping Chen, Xiaodan Huang, Li Lin, Xiaomin Zhang, (unknown), Yu‐Pei Chen, Ling‐Long Tang, Yan‐Ping Mao, Jun Ma	10
4	Iron Activates cGAS-STING Signaling and Promotes Hepatic Inflammation 2022 ·Journal of Agricultural and Food Chemistry ·(unknown), (unknown), Liwen Wang, (unknown), Yixuan Wang, (unknown), Yu‐Pei Chen, Wenlin Wu, Lei Wang	36
5	Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems 2021 ·Radiotherapy and Oncology ·Yan‐Ping Mao, Shunxin Wang, William M. Lydiatt, Jatin P. Shah, A. Dimitrios Colevas, Anne W.M. Lee, Brian O’Sullivan, Rui Guo, Wei‐Jie Luo, Yu‐Pei Chen, Li Tian, Ling‐Long Tang, Ying Sun, Lizhi Liu, Jian Ren, Jun Ma	41
6	Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial 2021 ·Radiotherapy and Oncology ·Siqi Tang, Lei Chen, Wen‐Fei Li, Anthony T.�C. Chan, Shao Hui Huang, Melvin L.K. Chua, Brian O’Sullivan, Anne W.M. Lee, Nancy Y. Lee, Yuan Zhang, Yu‐Pei Chen, Cheng Xu, Ying Sun, Ling‐Long Tang, Jun Ma	17
7	Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology 2020 ·Journal for ImmunoTherapy of Cancer ·Yaqin Wang, Lei Chen, Yan‐Ping Mao, Ying-Qing Li, Wei Jiang, Shuoyu Xu, Yu Zhang, Yu‐Pei Chen, Xiaomin Li, Qing‐Mei He, Shiwei He, Xiaojing Yang, Lei Yuan, Yin Zhao, Jing‐Ping Yun, Na Liu, Ying‐Qin Li, Jun Ma	32
8	Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual 2019 ·Oral Oncology ·Yaqin Wang, Jia-Wei Lv, Ling‐Long Tang, Xiao-Jing Du, Lei Chen, Wen-Fei Li, Xu Liu, Ying Guo, Ai-Hua Lin, Yan‐Ping Mao, Ying Sun, Yu‐Pei Chen, Jun Ma	9
9	Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma 2019 ·Nature Communications ·Jia‐Wei Lv, Yu‐Pei Chen, Guan‐Qun Zhou, Zhenyu Qi, (unknown), Haitao Wang, Li Lin, Fo‐Ping Chen, Lulu Zhang, Xiaodan Huang, Ruiqi Liu, Si‐Si Xu, Yue Chen, Jun Ma, Melvin L.K. Chua, Ying Sun	111
10	Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials 2019 ·Journal for ImmunoTherapy of Cancer ·Jia‐Wei Lv, Junyan Li, Linna Luo, Zixian Wang, Yu‐Pei Chen	55
11	Decoupling of economic growth and emissions in China’s cities: A case study of the Central Plains urban agglomeration 2019 ·Applied Energy ·Li Li, Yuli Shan, Yalin Lei, Sanmang Wu, Xiang Yu, (unknown), Yu‐Pei Chen	89
12	Optimizing the cumulative cisplatin dose during radiotherapy in nasopharyngeal carcinoma: Dose-effect analysis for a large cohort 2018 ·Oral Oncology ·Liang Peng, Cheng Xu, Yu‐Pei Chen, Rui Guo, Yan‐Ping Mao, Ying Sun, Jun Ma, Ling‐Long Tang	15
13	Prognostic significance of tumor‐infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large‐scale cohort study 2018 ·International Journal of Cancer ·Yaqin Wang, Yu‐Pei Chen, Yu Zhang, Wei Jiang, Na Liu, Jing‐Ping Yun, Ying Sun, Qing‐Mei He, Xin‐Ran Tang, Xin Wen, Xiaojing Yang, Panpan Zhang, Jian Zhang, Lei Yuan, Ying‐Qin Li, (unknown)	72
14	Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy 2018 ·Annals of Oncology ·Yu‐Pei Chen, (unknown), Jia Lv, Yiqi Li, Melvin L.K. Chua, Quynh‐Thu Le, N. Lee, A. Dimitrios Colevas, Tanguy Y. Seiwert, D. Neil Hayes, Nadeem Riaz, Jan B. Vermorken, Brian O’Sullivan, Qianting He, Xiaojun Yang, Ling‐Long Tang, Yan Mao, Ying Sun, Na Liu, Jun Ma	184
15	Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era 2017 ·Journal of the National Comprehensive Cancer Network ·Ling‐Long Tang, Yu‐Pei Chen, Yan‐Ping Mao, Zixian Wang, Rui Guo, Lei Chen, Li Tian, Ai-Hua Lin, Li Li, Ying Sun, Jun Ma	139
16	Do Published Data in Trials Assessing Cancer Drugs Reflect the Real Picture of Efficacy and Safety? 2017 ·Journal of the National Comprehensive Cancer Network ·Jia-Wei Lv, Yu‐Pei Chen, Guan‐Qun Zhou, Xu Liu, (unknown), Yan‐Ping Mao, Jun Ma, Ying Sun	5
17	Critical Evaluation of the Quality and Recommendations of Clinical Practice Guidelines for Nasopharyngeal Carcinoma 2017 ·Journal of the National Comprehensive Cancer Network ·Yu‐Pei Chen, Yaqin Wang, Wen-Fei Li, Lei Chen, Cheng Xu, Tai-Xiang Lu, Ai-Hua Lin, Ji‐Jin Yao, (unknown), Ying Sun, Yan‐Ping Mao, Jun Ma	16
18	A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma 2014 ·Annals of Oncology ·Yu‐Pei Chen, Zixian Wang, (unknown), Xuan Liu, Lin‐Quan Tang, Yan‐Ping Mao, W. F. Li, Ai Lin, Ying Sun, Jun Ma	87
19	Characteristics of Au/MgxAlO hydrotalcite catalysts in CO selective oxidation 2008 ·Journal of Molecular Catalysis A Chemical ·Ching-Tu Chang, Biing‐Jye Liaw, Yu‐Pei Chen, Yin‐Zu Chen, (unknown), (unknown)	15
20	The Formulation Design for Pioglitazone Rapid-Release Tablet 2000 ·Zhōnghuá yàoxué zázhì ·Gan‐Lin Chen, (unknown), Yu‐Pei Chen, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact